快速测试套件市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00038954
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 279
Buy Now

[研究报告]快速检测试剂盒市场预计将从2022年的177.2亿美元增长到2030年的266.3亿美元,2022-2030年复合年增长率为5.2%。
市场洞察和分析师观点:
快速检测试剂盒市场预测可以帮助该市场的利益相关者规划他们的增长战略。该报告包括由于当前快速检测试剂盒市场趋势及其在预测期内可预见的影响而产生的增长前景。
快速检测使用简单,可快速提供结果;它们通常被称为快速诊断测试 (RDT)。与大多数必须提交给实验室的常规测试相比,快速测试是在护理点进行的;此外,它们还能在护理时产生结果。这些试剂盒有助于识别和监测生物体内的潜在疾病。尽管快速检测试剂盒的主要目的是初步筛查,但事实证明它们在资源匮乏的情况下非常有用。快速检测试剂盒的主要应用是诊断传染病,例如 COVID-19、HIV、疟疾、链球菌性咽喉炎和流感。因此,遗传性疾病和传染病患病率上升等因素以及制造商的战略举措有助于快速检测试剂盒市场规模的扩大。然而,与结果准确性相关的不确定性阻碍了市场的增长。
增长动力:
遗传性疾病和传染病患病率的上升推动了快速检测试剂盒市场
根据健康指标与评估研究所的研究2000年至2021年间,全国镰状细胞病发病率相对稳定,但全球患有这种疾病的婴儿出生总数增加了13.7%。这一激增主要是由于各个地区的人口增长,尤其是加勒比地区以及撒哈拉以南非洲西部和中部地区。全球镰状细胞病患者估计增加了 41.4%,从 2000 年的 546 万增加到 2021 年的 774 万。Sickle SCAN 是一种快速检测镰状细胞贫血的方法,具有高灵敏度和特异性。
RDT 有助于通过检测人体血液中是否存在疟疾寄生虫来诊断疟疾。在获得高质量显微镜服务的机会有限的情况下,放射诊断技术被用作临床或基于显微镜的诊断的替代方法。 COVID-19 大流行对快速检测试剂盒市场产生了重大影响。几乎所有针对这种疾病的诊断测试都使用实时 PCR 来测试表现出 SARS-CoV-2 感染症状的人。快速检测试剂盒几乎无处不在、强大且可靠。大多数分子生物学实验室都使用快速测试技术,包括扩增特定 DNA 片段以进行基因分型、克隆和单核苷酸变异分析。因此,遗传性疾病和传染病发病率的增加推动了快速检测试剂盒市场的增长。
快速检测不发送到诊断实验室。此外,不同供应商提供的检测试剂盒之间的快速抗原检测的准确性也有所不同。例如,大多数专为艾滋病毒诊断而设计的快速检测可检测艾滋病毒抗体。一些快速检测试剂盒无法检测到 p24 抗原。然而,Determine HIV Early Detect 和Determine HIV-1/2 试剂盒可以检测p24 抗原。特别是在检测近期感染时,即时诊断的精度不一定与实验室检测程序的精度相同。此外,当用于没有感染症状的人时,COVID-19 的快速抗原检测的准确度要低得多,但在与 COVID-19 患者接触过的人中效果更好。因此,与测试准确性相关的限制阻碍了快速测试套件市场的增长。
战略见解
报告细分和范围:
快速测试套件市场分析是通过考虑以下细分市场进行的:类型、产品、技术、应用和最终用户。
细分分析:
按类型,快速检测试剂盒市场分为快速抗原检测、快速抗体检测等。快速抗原检测领域在 2022 年占据最大的市场份额。预计 2022 年至 2030 年复合年增长率最高为 6.0%。抗原进入宿主体内后会引起免疫反应。任何非宿主物质,如化学物质、病毒、细菌或毒素,都可以引发体内的免疫反应。身体组织和细胞中发现的抗原也会引起免疫反应。快速抗原检测的机制涉及检测收集的样本中的此类抗原。快速获得结果和易于使用是快速抗原检测试剂盒的主要优点。例如,iHealth COVID-19 抗原快速检测是 FDA 授权的非处方自我管理检测,可在 15 分钟内提供结果。
按技术划分,市场分为侧流检测、固体检测、相、凝集、免疫斑点测定和基于细胞成分的测定。侧流检测细分市场在 2022 年占据最大的快速检测试剂盒市场份额,预计 2022 年至 2030 年复合年增长率最高为 5.7%。侧流检测 (LFA) 是嵌入测试设备中的纸质平台检测或定量复杂混合物中的分析物。 5-30 分钟内即可获得明显结果。在医院、医生办公室和临床实验室中,基于 LFA 的测定经常用于特定抗原、抗体和基因/DNA 扩增产物的定性和定量检测。 LFA 可用于检查多种生物样品,例如全血、血清、血浆、汗液、唾液和尿液。侧流检测是一种有价值且适应性强的诊断工具,适用于现场护理环境。
按技术划分的快速检测试剂盒市场 – 2022 年和 2030 年
按产品划分的快速检测试剂盒市场分为-柜台快速检测试剂盒和专业快速检测试剂盒。非处方快速检测试剂盒细分市场在 2022 年占据更大的市场份额。预计 2022 年至 2030 年复合年增长率将达到 5.7%。现在市场上有大量快速家庭测试,可以提供快速、准确的结果。使用非处方快速检测试剂盒可以让用户在早期轻松了解感染状况,有助于防止病毒感染传播给他人。目前,所有 FDA 批准的可在家进行的 COVID-19 抗原检测都允许进行系列检测。 Mylab CoviSelf、Genabio COVID-19 快速自检试剂盒、FlowFlex COVID-19 抗原家庭测试和 Boson 快速 SARS-CoV-2 抗原检测卡是非处方快速检测试剂盒的一些示例。
按应用划分,市场分为血糖检测、传染病检测、心脏代谢检测、妊娠和生育等。血糖检测领域在 2022 年占据了最大的快速检测试剂盒市场份额,预计 2022 年至 2030 年复合年增长率最高,为 5.7%。血糖是人体能量的主要来源,通过血糖测试来确定。胰岛素是一种天然存在的激素,有助于细胞从血液中摄取葡萄糖。许多糖尿病患者发现血糖测试有助于控制疾病并预防并发症。可以采用多种方法来测量血糖。连续血糖监测仪 (CGM) 使用小型传感器 24/7 检测血糖水平。血糖监测有助于识别由饮食变化、体力活动、药物相互作用和糖尿病等病理过程引起的血糖(糖)波动趋势。
按最终用户划分,快速检测试剂盒市场分为两类:医院和诊所、诊断中心、家庭护理等。医院和诊所细分市场在 2022 年占据最大市场份额。家庭护理细分市场预计 2022 年至 2030 年复合年增长率最高,为 5.7%。医院和诊所可以使用现代化的设备,这使得这些设施中任命的工作人员能够提供有效和升级的医疗服务,例如诊断和疾病治疗。住院人数的增加以及慢性病患病率的上升,推动了医院领域全球快速检测试剂盒市场的增长。此外,新兴国家正在经历对先进医院环境的高需求,以满足庞大患者群体的需求和公共卫生问题。
区域分析:
快速检测试剂盒市场报告的地理范围包括北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。 2022年,北美占据最大市场份额。该地区的市场增长是由生物分析仪器制造商对创新产品的需求不断增长推动的。人们越来越关注在政府援助和私人医疗机构中采用先进的诊断方法,这促进了快速检测试剂盒的采用。
竞争格局和主要公司:
F. Hoffmann-La Roche Ltd、Becton Dickinson and Co、ARKRAY Inc、Sysmex Partec GmbH、Fujirebio Europe NV、bioMerieux SA、Cepheid、Meril Life Sciences Pvt Ltd、QIAGEN NV、OraSure Technologies Inc、广州万孚生物科技有限公司、Denka Co Ltd、 Abbott Laboratories、Trinity Biotech Plc、SD Biosensor Inc、Bio-Rad Laboratories Inc、Hologic Inc、DiaSorin SpA、Premier Medical Corp Pvt Ltd 和 Beckman Coulter Inc. 是快速检测试剂盒市场报告中介绍的知名公司之一。这些公司专注于开发新技术、升级现有产品并扩大其地域分布,以满足全球不断增长的消费者需求。
2021 年 6 月,DiaSorin SpA 推出了 LIAISON Murex AntiHEV IgG 和 IgM 测试,这是第一个完全自动化的高自动化测试。用于诊断戊型肝炎 (HEV) 的吞吐量 CLIA 测试。该测试已在所有承认 CE 标志的国家/地区的 LIAISON 平台上提供。 2022 年 11 月,OraSure Technologies 推出了 InteliSwab COVID-19 快速测试,该测试可在美国亚马逊在线商店上购买。该测试简单易用,因为它只需要用拭子擦拭下鼻孔并旋转预先测量的溶液。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is the fastest growing the rapid test kits market?

Asia Pacific is expected to be the fastest growing region in the rapid test kits market. The rapid test kits market in Asia Pacific is expected to register the highest CAGR during the forecast period. Market growth in the region is attributed to a surge in the use of antigen testing methods due to a rise in the number of cases of infectious diseases. Influenza, hepatitis B, AND infectious diarrhea are among the common infectious diseases in China, while India records typhoid, malaria, jaundice, tuberculosis, and AIDS cases in huge numbers.

Which end user segment is dominating the rapid test kits market?

The rapid test kits market by end user is categorized into hospitals and clinics, diagnostics centers, home care, and others. The hospital and clinics segment held the largest market share in 2022. The home care segment is anticipated to register the highest CAGR of 5.7% during 2022–2030.

Which application segment is dominating the rapid test kits market?

The rapid test kits market by application, is categorized into blood glucose testing, infectious disease testing, cardiometabolic testing, pregnancy and fertility, and others. The blood glucose testing segment held the largest rapid test kits market share in 2022 and is anticipated to register the highest CAGR of 5.7% during 2022–2023.

Which technology segment is dominating the rapid test kits market?

The rapid test kits market by technology is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest rapid test kits market share in 2022, and it is anticipated to register the highest CAGR of 5.7% during 2022– 2023.

Which product segment is dominating the rapid test kits market?

The rapid test kits market by product, is divided into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022. It is anticipated to register a higher CAGR of 5.7% during 2022–2023.

Which type segment is dominating the rapid test kits market?

The rapid test kits market, based on type, is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022. It is anticipated to register the highest CAGR of 6.0% during 2022– 2023.

Which country is dominated the rapid test kits market?

US holds the largest market share in rapid test kits market. There was a rapid increase in the use of at-home tests after the outbreak of the SARS-CoV-2 Delta- and Omicron variants. According to the CDC, in April 2023, more than 70 million test kits were shipped across the US. Moreover, the country is investing significantly in the establishment and operations of small biotechnology startups to provide support innovation through new analytical technologies such as real-time PCR.

Who are the major players in the rapid test kits market?

The rapid test kits market majorly consists of the players such as F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, SD Biosensor Inc, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, Premier Medical Corp Pvt Ltd, and Beckman Coulter Inc. among others.

What are the driving factors for the rapid test kits market across the globe?

The factors that are driving growth of the market are the rising prevalence of genetic and infectious diseases and strategic initiatives by manufacturers.

What is rapid test kits?

Rapid tests are simple to use and provide quick results; they are often referred to as rapid diagnostic tests (RDTs). Rapid tests are performed at the point of care, in contrast to the majority of routine tests, which have to be submitted to a lab; moreover, they generate results at the point of care. These kits aid in the identification and monitoring of underlying illnesses in living things. Although rapid test kits serve the primary purpose of initial screening, they prove highly beneficial in situations with scanty resource availability. The prime application of rapid test kits is to diagnose infectious disorders such as COVID-19, HIV, malaria, strep throat, and flu.

The List of Companies - Rapid Test Kits Market

  1. F. Hoffmann-La Roche Ltd
  2. Becton Dickinson and Co 
  3. ARKRAY Inc 
  4. Sysmex Partec GmbH 
  5. Fujirebio Europe NV
  6. bioMerieux SA
  7. Cepheid 
  8. Meril Life Sciences Pvt Ltd
  9. QIAGEN NV
  10. OraSure Technologies Inc 
  11. Guangzhou Wondfo Biotech Co Ltd
  12. Denka Co Ltd
  13. Abbott Laboratories
  14. Trinity Biotech Plc
  15. SD Biosensor Inc 
  16. Bio-Rad Laboratories Inc 
  17. Hologic Inc
  18. DiaSorin SpA
  19. Premier Medical Corp Pvt Ltd
  20. Beckman Coulter Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports